Jupiter Topco’s Benitec Biopharma BNTC Stock Holding History

Jupiter Topco’s Portfolio BNTC Stock Details BNTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.1M	Buy	+2,478,547	New	+$29.4M	0.01%	536

Other funds holding BNTC

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco's BNTC Position: Q2 2026 in Review

Jupiter Topco opened a new position in Benitec Biopharma (BNTC) in Q2 2026: 2,478,547 shares worth $33.1M. The stake represents 0.01% of the portfolio and ranks #536 among its holdings.

80 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

Jupiter Topco held 2,478,547 shares of Benitec Biopharma worth $33.1M as of Q2 2026.
Benitec Biopharma was a new Jupiter Topco position in Q2 2026.
Benitec Biopharma made up 0.01% of Jupiter Topco's portfolio in Q2 2026, its #536 holding.
80 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.